<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00708643</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0803</org_study_id>
    <nct_id>NCT00708643</nct_id>
  </id_info>
  <brief_title>Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <brief_summary>
    <textblock>
      This study seeks to evaluate the clinical and subjective performance of a new daily
      disposable soft contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Limbal Hyperemia</measure>
    <time_frame>At 2 weeks and 4 weeks</time_frame>
    <description>Measures the redness of the limbal region of the eye on a scale of 0 to 100 grade with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Comfort</measure>
    <time_frame>At 3,7,10,13,17,21,24, and 27 days</time_frame>
    <description>Rating of lens comfort by rating agreement to the following statement:
&quot;The lenses I am wearing are comfortable.&quot;
Rating using the following scale:
1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree. The rating is averaged over all time frames.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Upper Lid Margin Staining</measure>
    <time_frame>At 2 weeks and 4 weeks.</time_frame>
    <description>Measures the trauma to tissue that lines the margin of the inside of the upper eyelid on a 0 to 3 scale, with 0=none to 3=severe. The analysis is the average grade over all time frames.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tarsal Roughness</measure>
    <time_frame>At 2 weeks and 4 weeks</time_frame>
    <description>Measures the amount of roughness to the tissue of the inside upper and lower eyelid on a scale of 0 to 100 with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tarsal Hyperemia</measure>
    <time_frame>At 2 weeks and 4 weeks.</time_frame>
    <description>Measures the amount of redness to the tissue of the inside upper and lower eyelid using a 0 to 100 scale with 0=none and 100=severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Staining</measure>
    <time_frame>At 2 weeks and 4 weeks.</time_frame>
    <description>A measure of corneal abrasion using a 0 to 100 scale with 0=none, 25=micropunctate, 50=macropunctate, 75=coalescence, 100=patch. The analysis is the average grade over all time frames.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Habitual silicone hydrogel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Habitual contact lens wear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>narafilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Silicone hydrogel daily disposable contact lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Habitual Silicone Hydrogel Contact Lens</intervention_name>
    <description>contact lens</description>
    <arm_group_label>Habitual silicone hydrogel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>narafilcon A</intervention_name>
    <description>contact lens</description>
    <arm_group_label>narafilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. They are of legal age (17 years) and capacity to volunteer.

          2. They understand their rights as a research subject and are willing to sign a Statement
             of Informed Consent.

          3. They are willing and able to follow the protocol.

          4. They would be expected to attain at least 6/9 (20/30) in each eye with the study
             lenses.

          5. They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.

          6. They have a maximum of 1.00D of refractive astigmatism (i.e. â‰¤ 1.00 DC).

          7. They have successfully worn contact lenses within six months of starting the study.

        Exclusion Criteria:

          1. They have an ocular disorder which would normally contra-indicate contact lens wear.

          2. They have a systemic disorder which would normally contra-indicate contact lens wear.

          3. They are using any topical medication such as eye drops or ointment.

          4. They are aphakic.

          5. They have had corneal refractive surgery.

          6. They have any corneal distortion resulting from previous hard or rigid lens wear or
             has keratoconus.

          7. They are pregnant or lactating.

          8. They have grade 2 or greater of any of the following ocular surface signs: corneal
             oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any
             other abnormality which would normally contraindicate contact lens wear.

          9. They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease
             (e.g. HIV).

         10. They have diabetes.

         11. They have taken part in any other clinical trial or research, within two weeks prior
             to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>17 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre for Contact Lens Research</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2008</study_first_submitted>
  <study_first_submitted_qc>July 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2008</study_first_posted>
  <results_first_submitted>November 1, 2010</results_first_submitted>
  <results_first_submitted_qc>November 1, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 1, 2010</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Habitual Silicone Hydrogel</title>
          <description>Habitual contact lens wear.</description>
        </group>
        <group group_id="P2">
          <title>Narafilcon A</title>
          <description>Silicone hydrogel daily disposable contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Habitual Silicone Hydrogel</title>
          <description>Habitual contact lens wear.</description>
        </group>
        <group group_id="B2">
          <title>Narafilcon A</title>
          <description>Silicone hydrogel daily disposable contact lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Includes all subjects that completed the study.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.3" spread="9.9"/>
                    <measurement group_id="B2" value="25.8" spread="8.7"/>
                    <measurement group_id="B3" value="27.2" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Includes all subjects that completed the study.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>Includes all subjects that completed the study.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Limbal Hyperemia</title>
        <description>Measures the redness of the limbal region of the eye on a scale of 0 to 100 grade with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
        <time_frame>At 2 weeks and 4 weeks</time_frame>
        <population>The analysis includes all subjects that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Hyperemia</title>
          <description>Measures the redness of the limbal region of the eye on a scale of 0 to 100 grade with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
          <population>The analysis includes all subjects that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.0967" spread="1.4982"/>
                    <measurement group_id="O2" value="31.0920" spread="1.7271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that narafilcon A will provide a lower level of limbal hyperemia than the habitual lens.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-3.0047</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.2863</dispersion_value>
            <ci_percent>98.75</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.0047</ci_lower_limit>
            <ci_upper_limit>2.7153</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus the habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Comfort</title>
        <description>Rating of lens comfort by rating agreement to the following statement:
&quot;The lenses I am wearing are comfortable.&quot;
Rating using the following scale:
1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree. The rating is averaged over all time frames.</description>
        <time_frame>At 3,7,10,13,17,21,24, and 27 days</time_frame>
        <population>The analysis includes all subjects that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Lens Comfort</title>
          <description>Rating of lens comfort by rating agreement to the following statement:
&quot;The lenses I am wearing are comfortable.&quot;
Rating using the following scale:
1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree. The rating is averaged over all time frames.</description>
          <population>The analysis includes all subjects that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1078" spread="0.4993"/>
                    <measurement group_id="O2" value="1.0274" spread="0.5737"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that narafilcon A provides better comfort than the habitual lens by having a lower rating on the scale.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.0804</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.7605</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.0804</ci_lower_limit>
            <ci_upper_limit>1.8821</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Upper Lid Margin Staining</title>
        <description>Measures the trauma to tissue that lines the margin of the inside of the upper eyelid on a 0 to 3 scale, with 0=none to 3=severe. The analysis is the average grade over all time frames.</description>
        <time_frame>At 2 weeks and 4 weeks.</time_frame>
        <population>The analysis includes all subjects that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Upper Lid Margin Staining</title>
          <description>Measures the trauma to tissue that lines the margin of the inside of the upper eyelid on a 0 to 3 scale, with 0=none to 3=severe. The analysis is the average grade over all time frames.</description>
          <population>The analysis includes all subjects that completed the study.</population>
          <units>units on a scale.</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9358" spread="1.1146"/>
                    <measurement group_id="O2" value="1.1586" spread="1.2857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that narafilcon A provides a lowe level of upper lid margin staining than the habitual lens.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.2228</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.7002</dispersion_value>
            <ci_percent>99</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.2228</ci_lower_limit>
            <ci_upper_limit>4.6564</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus the habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tarsal Roughness</title>
        <description>Measures the amount of roughness to the tissue of the inside upper and lower eyelid on a scale of 0 to 100 with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
        <time_frame>At 2 weeks and 4 weeks</time_frame>
        <population>The analysis includes all subjects that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Tarsal Roughness</title>
          <description>Measures the amount of roughness to the tissue of the inside upper and lower eyelid on a scale of 0 to 100 with 0=none and 100=severe. The analysis is the average grade over all time frames.</description>
          <population>The analysis includes all subjects that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.1028" spread="0.7784"/>
                    <measurement group_id="O2" value="31.3624" spread="0.8994"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.2596</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.1873</dispersion_value>
            <ci_percent>98.75</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.2596</ci_lower_limit>
            <ci_upper_limit>4.2599</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus the habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tarsal Hyperemia</title>
        <description>Measures the amount of redness to the tissue of the inside upper and lower eyelid using a 0 to 100 scale with 0=none and 100=severe.</description>
        <time_frame>At 2 weeks and 4 weeks.</time_frame>
        <population>The analysis includes all subjects that completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Tarsal Hyperemia</title>
          <description>Measures the amount of redness to the tissue of the inside upper and lower eyelid using a 0 to 100 scale with 0=none and 100=severe.</description>
          <population>The analysis includes all subjects that completed the study.</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4103" spread="1.5238"/>
                    <measurement group_id="O2" value="37.5478" spread="1.7646"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that narafilcon A provides a lower level of tarsal hyperemia than the habitual lens.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.8625</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>2.3407</dispersion_value>
            <ci_percent>98.75</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.8625</ci_lower_limit>
            <ci_upper_limit>5.0524</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Staining</title>
        <description>A measure of corneal abrasion using a 0 to 100 scale with 0=none, 25=micropunctate, 50=macropunctate, 75=coalescence, 100=patch. The analysis is the average grade over all time frames.</description>
        <time_frame>At 2 weeks and 4 weeks.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Habitual Silicone Hydrogel</title>
            <description>Habitual contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Narafilcon A</title>
            <description>Silicone hydrogel daily disposable contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Staining</title>
          <description>A measure of corneal abrasion using a 0 to 100 scale with 0=none, 25=micropunctate, 50=macropunctate, 75=coalescence, 100=patch. The analysis is the average grade over all time frames.</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
                <count group_id="O2" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6173" spread="1.1106"/>
                    <measurement group_id="O2" value="6.3763" spread="1.2820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The alternative hypothesis is that narafilcon A provides lower levels of corneal staining than the habitual lens.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.2410</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.6975</dispersion_value>
            <ci_percent>98.75</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.2410</ci_lower_limit>
            <ci_upper_limit>4.0043</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as narafilcon A minus habitual lens.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Habitual Silicone Hydrogel</title>
          <description>Habitual contact lens wear.</description>
        </group>
        <group group_id="E2">
          <title>Narafilcon A</title>
          <description>Silicone hydrogel daily disposable contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody, O.D. FAOO</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

